[1] |
Canivell S, Gomis R. Diagnosis and classification of autoimmune diabetes mellitus. Autoimmun Rev, 2014; 13, 403-7. doi: 10.1016/j.autrev.2014.01.020 |
[2] |
International Diabetes Federation. Annual Report 2013-2014. http://www.idf.org/regions/EUR/annualreports. [2016-12-26] |
[3] |
Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010; 362, 1090-101. doi: 10.1056/NEJMoa0908292 |
[4] |
Ashcroft FM, Rorsman P. Diabetes mellitus and the beta cell: the last ten years. Cell, 2012; 14, 1160-71. |
[5] |
Hivert MF, Vassy JL, Meigs JB. Susceptibility to type 2 diabetes mellitus-from genes to prevention. Nat Rev Endocrinol, 2014; 10, 198-205. doi: 10.1038/nrendo.2014.11 |
[6] |
Hanson RL, Muller YL, Kobes S, et al. A genome-wide association study in American Indians implicates DNER as a susceptibility locus for type 2 diabetes. Diabetes, 2014; 63, 369-76. doi: 10.2337/db13-0416 |
[7] |
Ahlqvist E, Ahluwalia TS, Groop L. Genetics of type 2 diabetes. Clin Chem, 2011, 57; 241-54. doi: 10.1373/clinchem.2010.157016 |
[8] |
Li H, Lindholm E, Almgren P, et al. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes. J Clin Endocrinol Metab, 2001; 86, 574-82. https://www.researchgate.net/profile/Eero_Lindholm/publication/12171696_Possible_Human_Leukocyte_Antigen-Mediated_Genetic_Interaction_between_Type_1_and_Type_2_Diabetes_1/links/54ddb7180cf25b09b91484b1/Possible-Human-Leukocyte-Antigen-Mediated-Genetic-Interaction-between-Type-1-and-Type-2-Diabetes-1.pdf |
[9] |
Eftychi C, Howson JM, Barratt BJ, et al. Analysis of the type 2 diabetes-associated single nucleotide polymorphisms in the genes IRS1, KCNJ11, and PPARG2 in type 1 diabetes. Diabetes, 2004; 53, 870-3. doi: 10.2337/diabetes.53.3.870 |
[10] |
Kroetz MB. SUMO: a ubiquitin-like protein modifier. Yale J Biol Med, 2005; 78, 197-201. http://europepmc.org/articles/PMC2259148?pdf=render |
[11] |
Guo D, Li M, Zhang Y, et al. A functional variant of SUMO4, a new Ⅰ kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet, 2004; 36, 837-41. doi: 10.1038/ng1391 |
[12] |
Tsurumaru M, Kawasaki E, Ida H, et al. Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus in the Japanese population. J Clin Endocrinol Metab, 2006; 91, 3138-43. doi: 10.1210/jc.2006-0206 |
[13] |
Bohren KM, Nadkarni V, Song JH, et al. A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type Ⅰ diabetes mellitus. J Biol Chem, 2004; 279, 27233-8. doi: 10.1074/jbc.M402273200 |
[14] |
Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol, 2011; 11, 98-107. doi: 10.1038/nri2925 |
[15] |
Noso S, Fujisawa T, Kawabata Y, et al. Association of small ubiquitin-like modifier 4 (SUMO4) variant, located in IDDM5 locus, with type 2 diabetes in the Japanese population. J Clin Endocrinol Metab, 2007; 92, 2358-62. doi: 10.1210/jc.2007-0031 |
[16] |
Lin HY, Wang CL, Hsiao PJ, et al. SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes. Diabetes, 2007; 56, 1177-80. doi: 10.2337/db06-1283 |
[17] |
Ji Z, Dai Z, Xu Y. Association between small ubiquitin-like modifer 4 M55V polymorphism with type 2 diabetes and related factors. Chin J Diabetes Mellitus, 2010; 2, 344-8. (In Chinese) |
[18] |
Pu LM, Nan N, Yang ZN, et al. Association between SUMO4 polymorphisms and type 2 diabetes mellitus. Hereditas (Beijing), 2012; 3, 315-25. (In Chinese) |
[19] |
Sozen S, Horozoglu C, Bireller ES, et al. Association of SUMO4 M55V and-94ins/del gene variants with type-2 diabetes. In Vivo, 2014; 28, 919-23. http://iv.iiarjournals.org/content/28/5/919.full |
[20] |
Shimada T, Furukawa Y, Furuta H, et al. SUMO4 Met55Val polymorphism is associated with coronary heart disease in Japanese type 2 diabetes individuals. Diabetes Res Clin Pract, 2009; 85, 85-9. doi: 10.1016/j.diabres.2009.04.001 |
[21] |
Li B, Li HB, Wang YM, et al. The association of SUMO4 Gene 163 A/G polymorphism with type 2 diabetic nephropathy. Chin J Diabetes, 2011; 19, 726-8. (In Chinese) http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGTL201110004.htm |
[22] |
Fallah S, Jafarzadeh M, Hedayati M. No association of the SUMO4 polymorphism M55V variant in type 2 diabetes in Iranian subjects. Diabetes Res Clin Pract, 2010; 90, 191-5. doi: 10.1016/j.diabres.2010.05.033 |
[23] |
Hu RT, Song DP. The association of SUMO4 Gene 163 A/G polymorphism and dysglycemia in Va and Lalu population. Kunming Medical University, 2009. (In Chinese) |
[24] |
Tang ST, Peng WJ, Wang CJ, et al. Polymorphism M55V in gene encoding small ubiquitin-like modifier 4 (SUMO4) protein associates with susceptibility to type 1 (and type 2) diabetes. Diabetes Metab Res Rev, 2012; 28, 679-87. doi: 10.1002/dmrr.v28.8 |
[25] |
Meng QJ, Wang JS, Jiang J, et al. A meta-analysis on association between SUMO4 M55V polymorphism and type 2 diabetes mellitus. Chin J Diabetes, 2013; 21, 591-3. |
[26] |
Khodaeian M, Enayati S, Tabatabaei-Malazy O, et al. Association between Genetic Variants and Diabetes Mellitus in Iranian Populations: A Systematic Review of Observational Studies. J Diabetes Res, 2015; 2015, 585917. https://www.researchgate.net/publication/274631365_Association_between_Genetic_Variants_and_Diabetes_Mellitus_in_Iranian_Populations_A_Systematic_Review_of_Observational_Studies |
[27] |
Sale MM, Freedman BI, Langefeld CD, et al. A genome-wide scan for type 2 diabetes in African-American families reveals evidence for a locus on chromosome 6q. Diabetes, 2004; 53, 830-7. doi: 10.2337/diabetes.53.3.830 |
[28] |
Xiang K, Wang Y, Zheng T, et al. Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes, 2004; 53, 228-34. doi: 10.2337/diabetes.53.1.228 |
[29] |
Silander K, Scott LJ, Valle TT, et al. A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6, 11, and 14. Diabetes, 2004; 53, 821-9. doi: 10.2337/diabetes.53.3.821 |
[30] |
Song GG, Choi SJ, Ji JD, et al. Association between the SUMO4 M55V (A163G) polymorphism and susceptibility to type 1 diabetes: A meta-analysis. Human Immunology, 2012; 73, 1055-9. doi: 10.1016/j.humimm.2012.07.341 |
[31] |
Guo D, Li M, Zhang Y, et al. A functional variant of SUMO4, a new Ⅰ kappa B alpha modifier, is associated with type 1 diabetes. Nature Genetics, 2004; 36, 837-41. doi: 10.1038/ng1391 |
[32] |
Wang CY, Yang P, Li M, et al. Characterization of a negative feedback network between SUMO4 expression and NFkappaB transcriptional activity. Biochem Biophys Res Commun, 2009; 381, 477-81. doi: 10.1016/j.bbrc.2009.02.060 |
[33] |
Benzler J, Ganjam GK, Pretz D, et al. Central inhibition of IKKβ/NF-κB signaling attenuates high-fat diet-induced obesity and glucose intolerance. Diabetes, 2015; 64, 2015-27. doi: 10.2337/db14-0093 |
[34] |
Cai D, Yuan M, Frantz DF, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappa B. Nat Med, 2005; 11, 183-90. doi: 10.1038/nm1166 |
[35] |
Cyphert TJ, Morris RT, House LM, et al. NF-κB-dependent airway inflammation triggers systemic insulin resistance. Am J Physiol Regul Integr Comp Physiol, 2015; 309, R1144-52. doi: 10.1152/ajpregu.00442.2014 |
[36] |
Liu Z, Dou W, Ni Z, et al. Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-κB in mice fed a high-fat diet. Mol Med Rep, 2016; 1323-31. |
[37] |
Feng H, Su R, Song Y, et al. Positive Correlation between Enhanced Expression of TLR4/MyD88/NF-κB with Insulin Resistance in Placentae of Gestational Diabetes Mellitus. PLoS One, 2016; 11, e0157185. doi: 10.1371/journal.pone.0157185 |
[38] |
Ji Z, Dai Z, Huang Y, et al. Association of SUMO4 Met55Val variation with increased insulin resistance in newly diagnosed type 2 diabetes in a Chinese population. J Huazhong Univ Sci Technolog Med Sci, 2011; 31, 306-11. doi: 10.1007/s11596-011-0372-9 |